Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis.

Literature DB >> 5481516

Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis.

C V Ruckley, P C Das, A G Leitch, A A Donaldson, W A Copland, A T Redpath, P Scott, J D Cash.

Abstract

A total of 76 "high-risk" surgical patients were studied for evidence of venous thromboembolic disease. Episodes of deep vein thrombosis and of pulmonary embolism were related to changes in blood levels of fibrin degradation products (F.D.P.). When diagnosed either by ordinary clinical means or by venography and isotope scanning significantly raised F.D.P. levels were found in all cases. Serum F.D.P. estimations are unlikely to help in detecting deep vein thrombosis, but may prove valuable in diagnosing pulmonary embolism.

Entities: Disease Species

Mesh：

Substances：

Year: 1970 PMID： 5481516 PMCID： PMC1819952 DOI： 10.1136/bmj.4.5732.395

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

24 in total

Review 1. Treatment of pulmonary embolic disease. A critical review of some aspects of current therapy.

Authors: D P Thomas
Journal: N Engl J Med Date: 1965-10-21 Impact factor: 91.245

2. The post-mortem incdence of pulmonary embolism in a hospital population.

Authors: M T Morrell; M S Dunnill
Journal: Br J Surg Date: 1968-05 Impact factor: 6.939

3. Comparison of clinical and Doppler ultrasound evaluation of confirmed lower extremity venous disease.

Authors: B Sigel; G L Popky; D K Wagner; J P Boland; E M Mapp; P Feigl
Journal: Surgery Date: 1968-07 Impact factor: 3.982

Review 4. Pulmonary embolism.

Authors: D C Sabiston; W G Wolfe
Journal: Annu Rev Med Date: 1967 Impact factor: 13.739

5. Reflected ultrasound in the study of diseases of the chest.

Authors: C R Joyner; L D Miller; S J Dudrick; D J Eskin; P Bloom
Journal: Trans Am Clin Climatol Assoc Date: 1967

6. The angiographic diagnosis of acute pulmonary embolism: evaluation of criteria.

Authors: P D Stein; J F O'Connor; J E Dalen; A A Pur-Shahriari; F G Hoppin; D T Hammond; F W Haynes; F G Fleischner; L Dexter
Journal: Am Heart J Date: 1967-06 Impact factor: 4.749

7. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors: C Merskey; G J Kleiner; A J Johnson
Journal: Blood Date: 1966-07 Impact factor: 22.113

8. [A new method for the determination of fibrinolytic activity by means of immunoassay of breakdown products of fibrin and fibrinogen].

Authors: M Murakami; H Sekimoto; Y Yasuda; S Masuda; T Motoda
Journal: Rinsho Byori Date: 1965-10

7. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.

Authors: E F Plow; T S Edgington
Journal: J Clin Invest Date: 1975-12 Impact factor: 14.808

8. Pulmonary infarction, myocardial infarction, and acute disseminated intravascular coagulation.

Authors: F J Thomson; E W Benbow; R F McMahon; C M Cheshire
Journal: J Clin Pathol Date: 1991-12 Impact factor: 3.411

8 in total

Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis.

Review 1. Treatment of pulmonary embolic disease. A critical review of some aspects of current therapy.

2. The post-mortem incdence of pulmonary embolism in a hospital population.

3. Comparison of clinical and Doppler ultrasound evaluation of confirmed lower extremity venous disease.

Review 4. Pulmonary embolism.

5. Reflected ultrasound in the study of diseases of the chest.

6. The angiographic diagnosis of acute pulmonary embolism: evaluation of criteria.

7. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

8. [A new method for the determination of fibrinolytic activity by means of immunoassay of breakdown products of fibrin and fibrinogen].

9. Fibrin degradation products in sera of normal subjects.

10. Ultrasonic flow detection. A useful technic in the evaluation of peripheral vascular disease.

1. Fibrin degradation products in rheumatoid arthritis.

2. Postpartum purpura fulminans: successful management with streptokinase.

3. Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.

4. Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

5. Plasma cross linked fibrin degradation products in pulmonary embolism.

6. Measurement of fibrinogen-fibrin-related antigen in serum as aid to diagnosis of deep vein thrombosis in outpatients.

7. Immune responses to the cleavage-associated neoantigens of fibrinogen in man. Identification and characterization of humoral antibodies specific for cleavage fragments.

8. Pulmonary infarction, myocardial infarction, and acute disseminated intravascular coagulation.